Keros Therapeutics, Inc.

KROS

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001664710

SEC filings (opens in a new tab)

In the last 90 days, Keros Therapeutics, Inc. insiders filed 2 open-market purchases and 4 sales; 132 institutions reported holding it in 13F filings for Q2 2026, worth $198.6M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Keros Therapeutics, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of KROS: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	151	3	132	−16
Shares	18.6M	8.68K	18.6M	−34.1K (−0.2%)
Value	$205.6M	$95.8K	$198.6M	−$6.91M (−3.4%)

3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (14)

Institutions that held Keros Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to KROS in Q2 2026
Institution	Shares	Value	% of portfolio
O'Shaughnessy Asset Management, LLC	126,379	$1.35M	0.01%
Jain Global LLC	59,209	$633.5K	0.01%
Ieq Capital, LLC	55,675	$595.7K	0.00%
Susquehanna Portfolio Strategies, LLC	44,824	$479.6K	0.01%
Marshall Wace, LLP	34,600	$370.2K	0.00%
Squarepoint Ops LLC	31,204	$333.9K	0.00%
Wealth Enhancement Advisory Services, LLC	17,841	$210.5K	0.00%
Cerity Partners LLC	18,301	$195.8K	0.00%
nVerses Capital, LLC	13,124	$140.4K	0.22%
Jones Financial Companies LLLP	621	$6.83K	0.00%
Clearstead Advisors, LLC	113	$1.21K	0.00%
Wealth Enhancement Trust Services, Inc.	64	$685	0.00%
Silver Grove Financial Group, Inc.	8	$86	0.00%
Larson Financial Group LLC	5	$54	0.00%

Sold out (30)

Institutions that held Keros Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of KROS in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
HRT Financial LP	77,002	$850.0K
STRS Ohio	50,600	$558.6K
Globeflex Capital L P	37,873	$418.1K
Winton Group Ltd	36,433	$402.2K
Aviva PLC	34,307	$378.7K
Magnetar Financial LLC	30,085	$332.1K
Tudor Investment Corp Et Al	28,007	$309.2K
Simplex Trading, LLC	22,288	$246.1K
Fox Run Management, L.L.C.	22,790	$243.4K
Franklin Resources Inc	21,756	$240.2K
LSV Asset Management	20,900	$231.0K
State of Wisconsin Investment Board	15,932	$175.9K
Brevan Howard Capital Management LP	14,651	$161.7K
Virtus Investment Advisers, Inc.	12,676	$139.9K
Lazard Asset Management LLC	11,705	$129.2K
Oxford Asset Management LLP	11,153	$123.1K
SG Americas Securities, LLC	9,135	$101.0K
Signaturefd, LLC	1,280	$14.1K
Pinnacle Wealth Planning Services, Inc.	541	$5.97K
Private Wealth Asset Management, LLC	500	$5.52K
MAI Capital Management	412	$4.55K
Clear Street Markets LLC	153	$1.69K
Advisory Services Network, LLC	123	$1.36K
Natixis	100	$1.10K
Cornerstone Financial Management LLC	44	$486
Versant Capital Management, Inc	31	$342
JPL Wealth Management, LLC	12	$133
Keating Financial Advisory Services, Inc.	5	$55
Twin Peaks Wealth Advisors, LLC	2	$22
Hughes Financial Services, LLC	1	$11

Not filed for Q2 2026 yet (3)

Institutions that held Keros Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding KROS in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
CWM, LLC	8,618	$95.1K
Red Tortoise LLC	56	$618
Sunbelt Securities, Inc.	4	$44